Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole for scabies
PACTR202510613813428Phase 2Not yet recruiting
- Sponsor
- Center for Detection and Treatment of Leprosy and Buruli Ulcer of Pobe
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of albendazole in scabies, sponsored by Center for Detection and Treatment of Leprosy and Buruli Ulcer of Pobe. Primary endpoint: Clinical response to albendazole. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
albendazole
03
Conditions
scabies
Beyond the preview
Go deeper on PACTR202510613813428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510613813428.